Berotralstat dihydrochloride

Overview

Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Kallikrein

Product Information

• Catalog No.: HY-109127A
• CAS No.: 1809010-52-3
• Molecular Formula: C30H28Cl2F4N6O
• Molecular Weight: 635.48
• Purity: 98.67%
• Storage: 4°C, stored under nitrogen, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
• Solubility: ≥ 1.2 mg/mL (1.89 mM); Clear solution
• Availability: In-stock

Source

Original product source